Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Baricitinib was effective in treating alopecia areata in two major trials.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ginsenoside Re from Panax ginseng may prevent hair loss by maintaining autophagy and Wnt signaling in hair cells.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.